Abstract
A review was carried out of the published literature on survival rates for cancer in relation to patterns of organisation of medical care, specifically treatment at specialist centres or at hospitals treating larger numbers of patients and treatment by protocol, usually within the context of a clinical trial. Centralised referral or entry to trials was frequently associated with a higher survival rate, particularly for the less common cancers, and was never found to be associated with a lower survival rate. Few studies were identified for any one cancer site and some antedated current methods of treatment. At a time when the health service in the United Kingdom is undergoing far-reaching organisational change, further research is needed to establish the most beneficial patterns of care for people with cancer. Population-based cancer registries are an invaluable source of data for such studies.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Stiller, C. Centralised treatment, entry to trials and survival. Br J Cancer 70, 352–362 (1994). https://doi.org/10.1038/bjc.1994.306
Issue Date:
DOI: https://doi.org/10.1038/bjc.1994.306
This article is cited by
-
Management and outcomes of adolescent and young adult sarcoma patients: results from the French nationwide database NETSARC
BMC Cancer (2023)
-
DKG-Zertifizierung kinderonkologischer Zentren – ein weites Feld …
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz (2020)
-
Ambassadors of hope, research pioneers and agents of change—individuals’ expectations and experiences of taking part in a randomised trial of an innovative health technology: longitudinal qualitative study
Trials (2019)
-
Impact of clinical trial participation on survival in patients with castration-resistant prostate cancer: a multi-center analysis
BMC Cancer (2018)
-
Barriers to Clinical Trial Participation: A Comparison of Rural and Urban Communities in South Carolina
Journal of Community Health (2014)